Scientists have long suspected that respiratory viruses—the sort that cause common colds or bronchitis—play a critical role in chronic lung diseases such as asthma and chronic obstructive pulmonary disease (COPD).
A new study shows a potential link: immune cells dispatched to the lung to destroy a respiratory virus can fail to disperse after their job is finished, setting off a chain of inflammatory events that leads to long-term lung problems.
The findings stem from research into immune cells called macrophages.
“In general, scientists thought this type of macrophage was involved in the repair of the lung,” says senior author Michael J. Holtzman, a professor of medicine at Washington University School of Medicine in St. Louis. “That may be true in some cases. But like many things in nature, too much of a good thing can become a bad thing.”
When large numbers of this type of macrophage accumulate, they appear to stop orchestrating the immune response against acute viral infections and instead participate in a type of response that is more typically directed against parasites and allergens.
In a world first, Chinese scientists have reported editing the genomes of human embryos. The results are published1 in the online journal Protein & Cell and confirm widespread rumours that such experiments had been conducted—rumours that sparked a high-profile debate last month2, 3 about the ethical implications of such work.
In the paper, researchers led by Junjiu Huang, a gene-function researcher at Sun Yat-sen University in Guangzhou, tried to head off such concerns by using 'non-viable' embryos, which cannot result in a live birth, that were obtained from local fertility clinics. The team attempted to modify the gene responsible for β-thalassaemia, a potentially fatal blood disorder, using a gene-editing technique known as CRISPR/Cas9. The researchers say that their results reveal serious obstacles to using the method in medical applications.
"I believe this is the first report of CRISPR/Cas9 applied to human pre-implantation embryos and as such the study is a landmark, as well as a cautionary tale," says George Daley, a stem-cell biologist at Harvard Medical School in Boston. "Their study should be a stern warning to any practitioner who thinks the technology is ready for testing to eradicate disease genes."
Some say that gene editing in embryos could have a bright future because it could eradicate devastating genetic diseases before a baby is born. Others say that such work crosses an ethical line: researchers warned in Nature2 in March that because the genetic changes to embryos, known as germline modification, are heritable, they could have an unpredictable effect on future generations. Researchers have also expressed concerns that any gene-editing research on human embryos could be a slippery slope towards unsafe or unethical uses of the technique.
The paper by Huang's team looks set to reignite the debate on human-embryo editing — and there are reports that other groups in China are also experimenting on human embryos.
Scientists working in the area of pancreatic cancer research have uncovered a technique that sees cancerous cells transform back into normal healthy cells. The method relies in the introduction of a protein called E47, which bonds with particular DNA sequences and reverts the cells back to their original state.
The study was a collaboration between researchers at the Sanford-Burnham Medical Research Institute, University of California San Diego and Purdue University. The scientists are hopeful that it could help combat the deadly disease in humans.
"For the first time, we have shown that over-expression of a single gene can reduce the tumor-promoting potential of pancreatic adenocarcinoma cells and reprogram them toward their original cell type," says Pamela Itkin-Ansari, adjunct professor at Sanford-Burnham and lead author of the study. "Thus, pancreatic cancer cells retain a genetic memory which we hope to exploit."
One of the body's defenses against deadly cancer cells may have just received a much-needed boost. Researchers at Imperial College London have happened upon a previously unknown protein that ramps up the presence of all-important cytotoxic T cells, which destroy virus-infected and cancerous cells.
The scientists have named their discovery lymphocyte expansion molecule (LEM), which they unearthed while screening mice with genetic mutations. The found that a particular strain of mice was producing 10 times the normal amount of cytotoxic T cells once it had been infected with a virus. The result was an improved ability to contain the virus and a heightened resistance to cancer.
The cause for this boost in immune response, the scientists found, was the huge presence of a particular protein, their new friend LEM. Following this finding, the scientists were able to establish that LEM also regulates the levels of T cells in humans.
These findings could have important implications for the development of anti-cancer therapies. Though the immune system swiftly swings T cells into action once cancer is detected, they are also quickly overwhelmed and unable to spread widely enough to overcome the disease. If the number of T cells can be multiplied, especially if its by a factor of 10, it could bolster the immune systems chances of winning the battle.
A smartphone-based device developed by Harvard Medical School investigators at Massachusetts General Hospital could bring rapid, accurate molecular diagnosis of cancer and other diseases to locations lacking the latest medical technology.
The device uses technology for making holograms to collect detailed microscopic images for digital analysis of the molecular composition of cells and tissues.
“The global burden of cancer, limited access to prompt pathology services in many regions, and emerging cell profiling technologies increase the need for low-cost, portable and rapid diagnostic approaches that can be delivered at the point of care,” said Cesar Castro, HMS instructor in medicine at Mass General and co-lead author of a report in PNAS Early Edition.
“The emerging genomic and biological data for various cancers, which can be essential to choosing the most appropriate therapy, supports the need for molecular profiling strategies that are more accessible to providers, clinical investigators and patients.
People can control prosthetic limbs, computer programs and even remote-controlled helicopters with their mind, all by using brain-computer interfaces. What if we could harness this technology to control things happening inside our own body? A team of bioengineers in Switzerland has taken the first step toward this cyborglike setup by combining a brain-computer interface with a synthetic biological implant, allowing a genetic switch to be operated by brain activity. It is the world's first brain-gene interface.
The group started with a typical brain-computer interface, an electrode cap that can register subjects' brain activity and transmit signals to another electronic device. In this case, the device is an electromagnetic field generator; different types of brain activity cause the field to vary in strength. The next step, however, is totally new—the experimenters used the electromagnetic field to trigger protein production within human cells in an implant in mice.
Scientists at the National Institute of Standards and Technology (NIST) and the National Institutes of Health (NIH) have developed a new type of shape-shifting nanoprobe that can perform high-resolution remote biological sensing not possible with current technology. Around one-tenth the size of a single red blood cell, the nanoprobes are designed to provide feedback on internal body conditions by altering their magnetic fields in response to their environment. The researchers predict wide-spread applications for the nanoprobes in the fields of chemistry, biology, engineering and, one day, to aid physicians in high-accuracy clinical diagnostics.
Dubbed geometrically encoded magnetic sensors (GEMs), the nanoprobes are microengineered from two plates of magnetic metal disks 0.5 to 2 micrometers in diameter and just tens of nanometers thick. These are formed either side of a polymer gel to create a microminiature sandwiched component.
More specifically, the polymer is a layer of hydrogel, a network of polymer chains that are hydrophilic (absorb water) and are able to expand significantly dependent upon the level of the moisture in the environment in which they are used. Similarly, the gel can also contract when the environment is low in moisture. As such, the expanding or contracting of this gel then changes the distance between the two magnetic disks, and in turn increases or decreases the magnetic field.
Geographic tongue (GT) is a medical condition in which the upper layer of the tongue, which consists of tiny hair-like protrusions (called papillae), is damaged due to an expanding inflammation. As a result, red patches devoid of papillae can be observed on the surface of the tongue. A noticeable characteristic of the condition is an evolving map-like appearance of the affected tongue (hence its name).
GT, which is harmless and affects about 2% of the population, was first reported more than 180 years ago. It has been investigated ever since, but the actual cause of the condition remains unknown. GT has been associated with different diseases such as psoriasis. Maps and maths
In a recent investigation, published in New Journal of Physics, we treated GT as a dynamical system – a mathematical description that enables one to examine how something evolves over time – that consists of a large number of coupled (interacting) elements such as the hair protrusions. Each of these elements can be found in one of three states: a healed (unaffected) state, an excited state and a recovering state. Once an element is excited, it then goes through a remission period in which it cannot be excited.
Other well-known natural phenomena that can be treated in this manner include the heart muscle (where the cardiac cells are the coupled elements) and forest fires (where the trees are the elements) – once a fire has started, it then moves to fresh areas until it has burned everywhere that it can. The forest then enters a long recovering period and eventually completely recovers. Systems that can be described in this way fall in the category of “excitable media”.
A similar process also happens with GT. But as it is a chronic condition, it will reoccur at a later time. By identifying GT as a novel example of excitable media dynamics, we were able to examine and visualise the evolution of the condition using numerical simulations.
Even rats can imagine: A new study finds that rats have the ability to link cause and effect such that they can expect, or imagine, something happening even if it isn't. The findings are important to understanding human reasoning, especially in older adults, as aging degrades the ability to maintain information about unobserved events.
"What sets humans apart from the rest of the animal kingdom is our prodigious ability to reason. But what about human reasoning is truly a human-unique feature and what aspects are shared with our nonhuman relatives?," asks Aaron Blaisdell of the University of California, Los Angeles. "This is the question that drives my passion for research on rational behavior in rats."
Blaisdell hopes that his work with rats will teach us more about what it means to be human. His recent studies are part of a growing body of work on reasoning - the ability to figure out how to move from one state of affairs to another, to achieve a particular outcome.
From reasoning in rats to differences in reasoning among people with autism and schizophrenia, researchers are discussing the latest science on reasoning in a symposium today at the Cognitive Neuroscience Society (CNS) conference in San Francisco.
Bacteria frequently implicated in respiratory and urinary infections in hospitals may soon develop complete resistance to antibiotics, even those used as a last resort, experts warn.
A new study shows that two genes that confer resistance against a particularly strong class of antibiotics can be shared easily among a family of bacteria responsible for a significant portion of hospital-associated infections.
Drug-resistant germs in the same family of bacteria recently infected several patients at two Los Angeles hospitals. Those infections are linked to medical scopes believed to have been contaminated with bacteria that can resist carbapenems, potent antibiotics that are supposed to be used only in gravely ill patients or those infected by resistant bacteria.
“Carbapenems are one of our last resorts for treating bacterial infections, what we use when nothing else works,” says senior author Gautam Dantas, associate professor of pathology and immunologyat Washington University in St. Louis.
Scientists have developed a blood test using human stem cells that predicts whether new drugs will cause severe side effects. The test, which only requires blood from a single donor, could help prevent catastrophic inflammatory reactions known as a cytokine storm in people participating in drug trials.
"As biological therapies become more mainstream, it’s more likely that drugs being tested on humans for the first time will have unexpected and potentially catastrophic effects," says Professor Jane Mitchell from the National Heart and Lung Institute at Imperial College London, who led the study. "We’ve used adult stem cell technology to develop a laboratory test that could prevent another disaster like the TGN1412 trial."
In 2006 six healthy young men were hospitalized with multiple organ failure after experiencing a cytokine storm as a result of taking part in the first tests in humans of the drug TGN1412.
Tests on human cells are essential because biological therapies, or "biologics" (such as the cancer drugs Herceptin and Avastin), use antibodies which are specific to humans. They can cause severe reactions, such as a cytokine storm, that don’t occur in animal studies.
The Yanomami "had no exposure to modern antibiotics; their only potential intake of antibiotics could be through the accidental ingestion of soil bacteria that make naturally occurring versions of these drugs," says Erica Pehrsson. "Yet we were able to identify several genes in bacteria from their fecal and oral samples that deactivate natural, semi-synthetic, and synthetic drugs."
Though the pain they cause is minor and fleeting, a lot of people still find something pretty unsettling about needles. When it comes to conducting a routine blood test, US-based company Tasso Inc. believes that these unpleasant pricks can be removed from the equation completely. Its ping pong ball-sized HemoLink blood sampler can be operated by the patient at home, and needs only to be placed against the skin of the arm or abdomen for two minutes to do its job.
The roots of HemoLink can be traced back to the Tasso founders' research in microfluids at the University of Wisconsin-Madison. It was here that observations of circulating tumor cells, immune cells and visions of a medical device startup spawned the beginnings of Tasso Inc., which has just received US$3 million in funding from the Defense Advanced Research Projects Agency (DARPA).
HemoLink is designed as a low-cost, disposable device made from as few as six injection-molded plastic parts. Inside is a vacuum, which enables a small sample of blood to be drawn from tiny open channels into a small tube through a process known as capillary action. This process is made possible by forces that dictate the flow of tiny fluid streams, even against gravity.
"At these scales, surface tension dominates over gravity, and that keeps the blood in the channel no matter how you hold the device," says Tasso Inc.'s vice president and co-founder Ben Casavant.
Researchers can now make brain cells from the skin cells of patients with ALS, also known as Lou Gehrig’s disease, to better study the fatal disease.
The team used a genetic engineering technique to convert patients’ adult skin cells into “induced pluripotent stem cells,” which can then be coaxed into becoming brain cells.
“We make brain cells out of the patient’s own skin,” says Jeffrey Rothstein, professor of neurology, who directs the Brain Science Institute and the Robert Packard Center for ALS Research at Johns Hopkins University.
A psychedelic drink used for centuries in healing ceremonies is now attracting the attention of biomedical scientists as a possible treatment for depression. Researchers from Brazil last month published results from the first clinical test of a potential therapeutic benefit for ayahuasca, a South American plant-based brew. Although the study included just six volunteers and no placebo group, the scientists say that the drink began to reduce depression in patients within hours, and the effect was still present after three weeks. They are now conducting larger studies that they hope will shore up their findings.
The work forms part of a renaissance in studying the potential therapeutic benefits of psychedelic or recreational drugs—research that was largely banned or restricted worldwide half a century ago. Ketamine, which is used medically as an anaesthetic, has shown promise as a fast-acting antidepressant; psilocybin, a hallucinogen found in ‘magic mushrooms’, can help to alleviate anxiety in patients with advanced-stage cancer; MDMA (ecstasy) can alleviate post-traumatic stress disorder; and patients who experience debilitating cluster headaches have reported that LSD eases their symptoms.
Our tissue's inability to repair itself as we grow older is thought to correlate with the decline in the presence of stem cells. So it follows that if stem cell function can be preserved beyond the norm, it could have implications for the aging process and adverse effects of tissue degeneration, such as cancer. Scientists from the University of Toronto have followed this line of thinking through research on the mammary glands of genetically modified mice, finding that development of the tissue can be manipulated to avoid the effects of aging.
Led by Professor Rama Khoka, the researchers were investigating the relationship between enzymes that break down and then rebuild tissue, and the inhibitors that regulate this process. Known as metalloproteinases and tissue inhibitors of metalloproteinases (TIMPs), how these elements interact can dictate the health of the tissue, and whether it effectively regenerates or begins to deteriorate, possibly leading to cancer.
The researchers worked with mice engineered to be missing at least one of the four different kinds of TIMPs, experimenting with various combinations to observe the impacts on tissue. They discovered that removing TIMP1 and TIMP3 caused the number of stem cells to actually increase and continue to function, resulting in breast tissue that remained young throughout the mice's lives.
"Normally you would see these pools of stem cells, which reach their peak at six months in the mice, start to decline," says Khoka. "As a result, the mammary glands start to degenerate, which increases the risk of breast cancer occurring. However, we found that in these particular mice, the stem cells remained consistently high when we measured them at every stage of life."
Technology’s promise of wonderful things in the future stretches from science fiction to science fact: self-driving cars, virtual reality, smart devices such as Google Glass, and the internet of things are designed to make our lives easier and more productive. Certainly inventions of the past century such as the washing machine and combustion engine have brought leisure time to the masses. But will this trend necessarily continue?
On the surface, tech that simplifies hectic modern lives seems a good idea. But we risk spending more of the time freed by these devices designed to free up our time through the growing need to micromanage them. Recall that an early digital technology designed to help us was the continually interrupting Microsoft Office paperclip.
It’s possible that internet-connected domestic devices could turn out to be ill-judged, poorly-designed, short-lived technological fads. But the present trend of devices that require relentless updates and patches driven by security threats and privacy breaches doesn’t make for a utopian-sounding future. Technology growth in the workplace can lead to loss of productivity; taken to the home it could take a bite out of leisure time too.
All the information available online has a strange effect on our brains: We feel a lot smarter than we really are, a new study shows.
In 9 different experiments with more than 1,000 participants, Yale University psychologists found that if subjects received information through internet searches, they rated their knowledge base as much greater than those who obtained the information through other methods.
“This was a very robust effect, replicated time and time again,” says Matthew Fisher, a PhD student and the lead author of the study. “People who search for information tend to conflate accessible knowledge with their own personal knowledge.”
For instance, in one experiment people searched online for a website that answers the question, “How does a zipper work?” The control group received the same answer that they would have found online, but without searching for it themselves.
When later asked how well they understood completely unrelated domains of knowledge, those who searched online rated their knowledge substantially greater than those who were only provided text. Prior to the experiment, no such difference existed.
The effect was so strong that even when a full answer to a question was not provided to internet searchers, they still had an inflated sense of their own knowledge.
“The cognitive effects of ‘being in search mode’ on the internet may be so powerful that people still feel smarter even when their online searches reveal nothing,” says Frank Keil, professor of psychology and linguistics and senior author of the paper.
(MedicalXpress)—Resting state networks (RSNs) in the brain are topographies of neural structures between which lag states propagate due to fluctuations of physical and other activities. Studying these networks reveals information about the functional connectivity of neural structures and regions. Results from various studies have confirmed that brain activity is spatially structured, linked to the representation of function, and has clinical relevance.
Functional connectivity is different from the brain's structural connectivity, which describes brain regions that are anatomically attached to each other. Regions with no structural connectivity can nonetheless have functional connectivity as nodes in a functionally connected RSN. Many common RSNs have been mapped in healthy subjects, and researchers believe that understanding the relationships between these networks can contribute to a fundamental model of brain function.
One of the tremendous advantages of functional magnetic resonance imaging (fMRI) is the ability to study brain functional activity without the need for subjects to perform complex tasks. Using fMRI to study resting-state functional connectivity yields a wealth of information about different stages of consciousness and patterns of synchronous activity. One of the neurological features that has emerged from such research is the existence of lags in intrinsic activity as represented by fluctuations of the blood-oxygen level-dependent signals (BOLDs), which are temporally synchronous within the somatomotor system.
Last year, researchers at the departments of radiology and neurology at Washington University published an analysis demonstrating that, contrary to the belief that BOLDs were synchronous with resting state networks (RSNs), the lag topography of BOLDs and RSNs is actually orthogonal. Additionally, they established that BOLDs are not attributable to hemodynamic factors and have neural origin.
Scientists have developed “nanoneedles” that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice.
The researchers, from Imperial College London and Houston Methodist Research Institute in the USA, hope their nanoneedle technique could ultimately help damaged organs and nerves repair themselves and help transplanted organs thrive.
In a trial described in Nature Materials, the team showed they could deliver nucleic acids DNA and siRNA to back muscles in mice. After seven days there was a six-fold increase in the formation of new blood vessels in the mouse back muscles, and blood vessels continued to form over a 14 day period.
The nanoneedles are tiny porous structures that act as a sponge to load significantly more nucleic acids than solid structures. This makes them more effective at delivering their payload. They can penetrate the cell, bypassing its outer membrane, to deliver nucleic acids without harming or killing the cell.
The nanoneedles are made from biodegradable silicon, meaning that they can be left in the body without leaving a toxic residue behind. The silicon degrades in about two days, leaving behind only a negligible amount of a harmless substance called orthosilicic acid.
Washington State University researchers have found that an unexpectedly high percentage of young people experience "exploding head syndrome," a psychological phenomenon in which they are awakened by abrupt loud noises, even the sensation of an explosion in their head. Brian Sharpless, a Washington State University assistant professor and director of the university psychology clinic, found that nearly one in five—18 percent—of college students interviewed said they had experienced it at least once. It was so bad for some that it significantly impacted their lives, he said."Unfortunately for this minority of individuals, no well-articulated or empirically supported treatments are available, and very few clinicians or researchers assess for it," he said.
The study also found that more than one-third of those who had exploding head syndrome also experienced isolated sleep paralysis, a frightening experience in which one cannot move or speak when waking up. People with this condition will literally dream with their eyes wide open.The study is the largest of its kind, with 211 undergraduate students interviewed by psychologists or graduate students trained in recognizing the symptoms of exploding head syndrome and isolated sleep paralysis. The results appear online in the Journal of Sleep Research.Based on smaller, less rigorous studies, some researchers have hypothesized that exploding head syndrome is a rare condition found mostly in people older than 50.
Physicians assistants are highly paid medical professionals who provide a lot of the same healthcare services that doctors do. They take patient histories and perform physical exams, diagnose illnesses and develop treatment plans, prescribe medications and counsel patients. And in surgical settings, they suture wounds and assist with the procedures. PAs, as they’re known in the industry, typically earn master’s degrees in medical science before practicing. These programs usually last three academic years and include classroom instruction in topics ranging from anatomy to pharmacology. Students also participate in more than 2,000 hours of clinical rotations. This training entails a lot of rigorous coursework—education that would, in theory, be hard to deliver outside the brick-and-mortar walls of the 175 or so higher-education institutions with accredited PA master’s programs.
Or maybe not. Soon, an aspiring PA might be able to complete nearly all this coursework online—and through an Ivy League to boot: Yale.
Yale announced earlier this month that it’s partnering with 2U, Inc.—a firm that helps selective nonprofit universities develop virtual degree programs—to launch its online PA initiative. The project is still pending approval by the accrediting commission for PA schools and from various state licensing agencies. But if it gets the green light, it would likely be the country’s first fully online PA degree. (Some programs are considered "hybrid" and entail a combination of on-campus and online coursework.) It would also become Yale’s first fully online master’s program and join the university’s existing on-campus PA program, which was launched in the early 1970s. The online program would cost the same as the on-campus one, whose sticker price is $35,654 annually for the first two years, excluding other fees.
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.